Search alternatives:
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
ng decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
e fold » _ fold (Expand Search), 5 fold (Expand Search), 2 fold (Expand Search)
Showing 301 - 320 results of 100,362 for search '(( 5 ((((ng decrease) OR (nn decrease))) OR (a decrease)) ) OR ( e fold decrease ))', query time: 1.58s Refine Results
  1. 301
    CCS1477 decreases phosphorylated ATR (pATR) and phosphorylated ATM (pATM).

    CCS1477 decreases phosphorylated ATR (pATR) and phosphorylated ATM (pATM). by Changkun Hu (12077989)

    Published 2022
    Save to List
    Saved in:
  2. 302
    Klf5 expression is down-regulated in the ruptured human and experimental AAA.

    Klf5 expression is down-regulated in the ruptured human and experimental AAA. by Dong Ma (584680)

    Published 2020
    Subjects:
    Save to List
    Saved in:
  3. 303
    Selective downregulation of SR Ca<sup>2+</sup> handling proteins and decreased SR Ca<sup>2+</sup> uptake in TG mice hearts.

    Selective downregulation of SR Ca<sup>2+</sup> handling proteins and decreased SR Ca<sup>2+</sup> uptake in TG mice hearts. by Mayilvahanan Shanmugam (691549)

    Published 2015
    “…For each atrial Ca<sup>2+</sup> uptake experiment, atria from four mice were pooled. n = 4 for each group. The V<sub>max</sub> of Ca<sup>2+</sup> uptake was obtained at pCa 5.5.…”
    Save to List
    Saved in:
  4. 304
    RTA 408 Increases Expression of Nrf2 Target Genes and Decreases Expression of Inflammatory Mediators in RAW 264.7 Cells.

    RTA 408 Increases Expression of Nrf2 Target Genes and Decreases Expression of Inflammatory Mediators in RAW 264.7 Cells. by Brandon L. Probst (727964)

    Published 2015
    Save to List
    Saved in:
  5. 305
    Clinical characteristics of patients in the increased-, stable-, and decreased-RPR groups.

    Clinical characteristics of patients in the increased-, stable-, and decreased-RPR groups. by Kazuhiko Ikeuchi (9234268)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  6. 306
    Fig 7 -

    Fig 7 - by Henning Carstens (13132801)

    Published 2022
    Save to List
    Saved in:
  7. 307
    Down-regulation of pol III activity in hypoxia is not due to a decrease in the abundance of TFIIIB, TFIIIC or pol III subunits

    Down-regulation of pol III activity in hypoxia is not due to a decrease in the abundance of TFIIIB, TFIIIC or pol III subunits by Isabelle Ernens (13462)

    Published 2011
    Save to List
    Saved in:
  8. 308
    Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells.

    Decreased hypotaurine levels within cells lacking the ADO gene in U251 cells. by Hong Tian (169626)

    Published 2025
    Save to List
    Saved in:
  9. 309
    Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity.

    Pretreatment of β-cells with recombinant CXCL12 improves viability and induces a decrease in PARP-1 activity. by Nevena Grdović (394542)

    Published 2014
    Save to List
    Saved in:
  10. 310
    Evaluation of the PCSK9 vaccine (V2 vaccine) in male <i>ApoE-deficient mice</i> (N = 5–7).

    Evaluation of the PCSK9 vaccine (V2 vaccine) in male <i>ApoE-deficient mice</i> (N = 5–7). by Ryo Kawakami (4849549)

    Published 2018
    Save to List
    Saved in:
  11. 311
    Demographics and baseline characteristics of the safety population.

    Demographics and baseline characteristics of the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  12. 312
    iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model.

    iOWH032 inhibits cholera toxin-induced secretion in a mouse closed-loop model. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  13. 313
    Grading of stool consistency and diarrhea severity.

    Grading of stool consistency and diarrhea severity. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 314
    Secondary efficacy endpoints for the modified intent-to-treat population.

    Secondary efficacy endpoints for the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  15. 315
    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population.

    Study drug–related treatment-emergent adverse events by system organ class and preferred term in the safety population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 316
    Source data for Fig 1.

    Source data for Fig 1. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 317
    Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population.

    Diarrheal stool output rate overall and by blood type status in the modified intent-to-treat population. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  18. 318
    Source data for S1 and S2 Figs.

    Source data for S1 and S2 Figs. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  19. 319
    Source data for Fig 2.

    Source data for Fig 2. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 320
    Consolidated Standards for Reporting of Trials flow diagram.

    Consolidated Standards for Reporting of Trials flow diagram. by Rahsan Erdem (11726357)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: